Free Trial
NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

Health Catalyst logo
$1.16 -0.19 (-13.81%)
As of 12:06 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Health Catalyst Stock (NASDAQ:HCAT)

Advanced

Key Stats

Today's Range
$1.15
$1.33
50-Day Range
$1.00
$1.95
52-Week Range
$0.96
$4.29
Volume
797,201 shs
Average Volume
756,540 shs
Market Capitalization
$85.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.77
Consensus Rating
Hold

Company Overview

Health Catalyst Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

HCAT MarketRank™: 

Health Catalyst scored higher than 50% of companies evaluated by MarketBeat, and ranked 562nd out of 864 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Health Catalyst has received a consensus rating of Hold. The company's average rating score is 2.23, and is based on no strong buy ratings, 4 buy ratings, 8 hold ratings, and 1 sell rating.

  • Upside Potential

    Health Catalyst has a consensus price target of $2.77, representing about 106.9% upside from its current price of $1.34.

  • Amount of Analyst Coverage

    Health Catalyst has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Health Catalyst's stock forecast and price target.
  • Earnings Growth

    Earnings for Health Catalyst are expected to grow in the coming year, from ($0.28) to ($0.23) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Health Catalyst is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Health Catalyst is -0.36, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Health Catalyst has a P/B Ratio of 0.72. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    10.58% of the float of Health Catalyst has been sold short.
  • Short Interest Ratio / Days to Cover

    Health Catalyst has a short interest ratio ("days to cover") of 13.87, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Health Catalyst has recently increased by 0.38%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Health Catalyst does not currently pay a dividend.

  • Dividend Growth

    Health Catalyst does not have a long track record of dividend growth.

  • News Sentiment

    Health Catalyst has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 17 news articles for Health Catalyst this week, compared to 3 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Health Catalyst insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    2.60% of the stock of Health Catalyst is held by insiders.

  • Percentage Held by Institutions

    85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Health Catalyst's insider trading history.
Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HCAT Stock News Headlines

Millionaire warns: Move your money now
Larry Benedict, the hedge fund trader who generated $274 million in profits for clients and beat the S&P 500 by 18 times in 2025, says Trump's installation of a new Federal Reserve chair is triggering the most significant shift in U.S. markets in nearly 20 years. Benedict's track record around Fed moves is hard to ignore - 62% from a single position after 2020 rate cuts, 117% in under a month when rate hikes were signaled in 2022, and an 89% gain in 17 days following a Jackson Hole speech. He has already identified the one ticker he believes will be at the center of the coming money flows, and he's sharing it free.tc pixel
Health Catalyst Reports First Quarter 2026 Results
Health Catalyst (HCAT) Q1 2026 Earnings Transcript
See More Headlines

HCAT Stock Analysis - Frequently Asked Questions

Health Catalyst's stock was trading at $2.39 at the start of the year. Since then, HCAT stock has decreased by 43.9% and is now trading at $1.34.

Health Catalyst, Inc. (NASDAQ:HCAT) released its quarterly earnings results on Monday, May, 11th. The company reported $0.02 EPS for the quarter, topping analysts' consensus estimates of $0.01 by $0.01. The company had revenue of $70.76 million for the quarter, compared to analysts' expectations of $69.24 million. Health Catalyst had a negative trailing twelve-month return on equity of 3.52% and a negative net margin of 87.69%.
Read the conference call transcript
.

Health Catalyst (HCAT) raised $172 million in an initial public offering on Wednesday, July 24th 2019. The company issued 7,000,000 shares at $24.00-$25.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Top institutional investors of Health Catalyst include Dimensional Fund Advisors LP (1.68%), Sei Investments Co. (0.23%), Hsbc Holdings PLC (0.13%) and State of Wyoming (0.04%). Insiders that own company stock include Bryan Truman Hunt, Kevin Lee Freeman, Daniel Lesueur, Benjamin Landry, Jason Alger, Linda Llewelyn, Julie Larson-Green and Duncan Gallagher.
View institutional ownership trends
.

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/11/2026
Today
5/14/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Computer Software
Current Symbol
NASDAQ:HCAT
CIK
1636422
Fax
N/A
Employees
1,200
Year Founded
2008

Price Target and Rating

High Price Target
$5.00
Low Price Target
$1.00
Potential Upside/Downside
+135.0%
Consensus Rating
Hold
Rating Score (0-4)
2.23
Research Coverage
13 Analysts

Profitability

EPS (Trailing Twelve Months)
($2.54)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$177.97 million
Net Margins
-87.69%
Pretax Margin
-87.39%
Return on Equity
-3.52%
Return on Assets
-1.77%

Debt

Debt-to-Equity Ratio
1.10
Current Ratio
1.69
Quick Ratio
1.89

Sales & Book Value

Annual Sales
$311.14 million
Price / Sales
0.28
Cash Flow
$1.69 per share
Price / Cash Flow
0.70
Book Value
$1.87 per share
Price / Book
0.63

Miscellaneous

Outstanding Shares
73,890,000
Free Float
71,673,000
Market Cap
$87.19 million
Optionable
Optionable
Beta
1.63

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:HCAT) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners